MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/ijms23158146

Медицинская библиотека · International journal of molecular sciences · 2022

A microRNA Signature for the Diagnosis of Statins Intolerance.

Mangas Alipio, Pérez-Serra Alexandra, Bonet Fernando, Muñiz Ovidio, Fuentes Francisco, Gonzalez-Estrada Aurora, Campuzano Oscar, Rodriguez Roca Juan Sebastian, Alonso-Villa Elena, Toro Rocio

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

Atherosclerotic cardiovascular diseases (ASCVD) are the leading cause of morbidity and mortality in Western societies. Statins are the first-choice therapy for dislipidemias and are considered the cornerstone of ASCVD. Statin-associated muscle symptoms are the main reason for dropout of this treatment. There is an urgent need to identify new biomarkers with discriminative precision for diagnosing intolerance to statins (SI) in patients. MicroRNAs (miRNAs) have emerged as evolutionarily conserved molecules that serve as reliable biomarkers and regulators of multiple cellular events in cardiovascular diseases. In the current study, we evaluated plasma miRNAs as potential biomarkers to discriminate between the SI vs. non-statin intolerant (NSI) population. It is a multicenter, prospective, case-control study. A total of 179 differentially expressed circulating miRNAs were screened in two cardiovascular risk patient cohorts (high and very high risk): (i) NSI (n = 10); (ii) SI (n = 10). Ten miRNAs were identified as being overexpressed in plasma and validated in the plasma of NSI (n = 45) and SI (n = 39). Let-7c-5p, let-7d-5p, let-7f-5p, miR-376a-3p and miR-376c-3p were overexpressed in the plasma of SI patients. The receiver operating characteristic curve analysis supported the discriminative potential of the diagnosis. We propose a three-miRNA predictive fingerprint (let-7f, miR-376a-3p and miR-376c-3p) and several clinical variables (non-HDLc and years of dyslipidemia) for SI discrimination; this model achieves sensitivity, specificity and area under the receiver operating characteristic curve (AUC) of 83.67%, 88.57 and 89.10, respectively. In clinical practice, this set of miRNAs combined with clinical variables may discriminate between SI vs. NSI subjects. This multiparametric model may arise as a potential diagnostic biomarker with clinical value.

Для цитирования: Mangas Alipio, Pérez-Serra Alexandra, Bonet Fernando, Muñiz Ovidio, Fuentes Francisco, Gonzalez-Estrada Aurora, Campuzano Oscar, Rodriguez Roca Juan Sebastian, Alonso-Villa Elena, Toro Rocio. A microRNA Signature for the Diagnosis of Statins Intolerance.. International journal of molecular sciences. 2022. DOI: 10.3390/ijms23158146.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.